[go: up one dir, main page]

FI943499L - Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja - Google Patents

Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja Download PDF

Info

Publication number
FI943499L
FI943499L FI943499A FI943499A FI943499L FI 943499 L FI943499 L FI 943499L FI 943499 A FI943499 A FI 943499A FI 943499 A FI943499 A FI 943499A FI 943499 L FI943499 L FI 943499L
Authority
FI
Finland
Prior art keywords
benzazepinones
tetrahydro
containing acid
acid substituents
substituents
Prior art date
Application number
FI943499A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943499A0 (fi
FI943499A7 (fi
Inventor
Iii John A Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943499A0 publication Critical patent/FI943499A0/fi
Publication of FI943499L publication Critical patent/FI943499L/fi
Publication of FI943499A7 publication Critical patent/FI943499A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI943499A 1993-07-26 1994-07-25 Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja FI943499A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9764093A 1993-07-26 1993-07-26

Publications (3)

Publication Number Publication Date
FI943499A0 FI943499A0 (fi) 1994-07-25
FI943499L true FI943499L (fi) 1995-01-27
FI943499A7 FI943499A7 (fi) 1995-01-27

Family

ID=22264420

Family Applications (4)

Application Number Title Priority Date Filing Date
FI943499A FI943499A7 (fi) 1993-07-26 1994-07-25 Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja
FI992038A FI19992038L (fi) 1993-07-26 1999-09-23 Menetelmä atsepinonien valmistamiseksi
FI992039A FI19992039L (fi) 1993-07-26 1999-09-23 Menetelmä atsepinonien valmistamiseksi
FI992037A FI19992037L (fi) 1993-07-26 1999-09-23 Menetelmä atsepinonien valmistamiseksi

Family Applications After (3)

Application Number Title Priority Date Filing Date
FI992038A FI19992038L (fi) 1993-07-26 1999-09-23 Menetelmä atsepinonien valmistamiseksi
FI992039A FI19992039L (fi) 1993-07-26 1999-09-23 Menetelmä atsepinonien valmistamiseksi
FI992037A FI19992037L (fi) 1993-07-26 1999-09-23 Menetelmä atsepinonien valmistamiseksi

Country Status (13)

Country Link
US (1) US5618811A (fr)
EP (1) EP0711283B1 (fr)
JP (1) JP2862675B2 (fr)
AT (1) ATE181323T1 (fr)
AU (1) AU6686694A (fr)
CA (1) CA2168131C (fr)
DE (1) DE69419157T2 (fr)
DK (1) DK0711283T3 (fr)
ES (1) ES2132401T3 (fr)
FI (4) FI943499A7 (fr)
GR (1) GR3030816T3 (fr)
IL (1) IL110349A0 (fr)
WO (1) WO1995003281A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
EP0977773A1 (fr) 1997-04-14 2000-02-09 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
JP2001523226A (ja) 1997-04-14 2001-11-20 シーオーアール セラピューティクス インコーポレイテッド 選択的Ｘａ因子阻害剤
EP0975625A1 (fr) 1997-04-14 2000-02-02 Cor Therapeutics, Inc. INHIBITEURS SELECTIFS DU FACTEUR Xa
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
JP2002536411A (ja) * 1999-02-09 2002-10-29 ブリストル−マイヤーズ スクイブ カンパニー Ｘａ因子のラクタム系阻害剤および方法
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
US6319915B1 (en) * 1999-08-27 2001-11-20 Pfizer Inc. Benzazepine derivatives as inhibitors of hyperproliferation diseases
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
AU2006255047B2 (en) * 2005-06-06 2011-09-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating sleep disorders
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04210967A (ja) * 1989-12-28 1992-08-03 Yoshitomi Pharmaceut Ind Ltd ２−ベンズアゼピン化合物
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
TW213901B (fr) * 1992-01-27 1993-10-01 Pfizer

Also Published As

Publication number Publication date
FI19992037A7 (fi) 1999-09-23
FI19992039A7 (fi) 1999-09-23
ES2132401T3 (es) 1999-08-16
DE69419157D1 (de) 1999-07-22
FI943499A0 (fi) 1994-07-25
FI19992039L (fi) 1999-09-23
DE69419157T2 (de) 1999-10-14
US5618811A (en) 1997-04-08
DK0711283T3 (da) 1999-11-22
CA2168131C (fr) 1998-10-06
AU6686694A (en) 1995-02-20
FI19992038A7 (fi) 1999-09-23
EP0711283B1 (fr) 1999-06-16
WO1995003281A1 (fr) 1995-02-02
FI19992038L (fi) 1999-09-23
CA2168131A1 (fr) 1995-02-02
FI943499A7 (fi) 1995-01-27
ATE181323T1 (de) 1999-07-15
EP0711283A1 (fr) 1996-05-15
FI19992037L (fi) 1999-09-23
GR3030816T3 (en) 1999-11-30
JPH08508039A (ja) 1996-08-27
JP2862675B2 (ja) 1999-03-03
IL110349A0 (en) 1994-10-21

Similar Documents

Publication Publication Date Title
FI954404L (fi) Fenoksifenyylietikkahappojohdannaiset
FI933260A7 (fi) Heteroaettiksyraderivat
FI954250L (fi) Kiteinen vapaa keftiofuurihappo
DE69405554D1 (de) Peroxysaeure
BR1101108A (pt) Composto
FI954327L (fi) Atsasykloheksapeptidiyhdisteitä
BR9408121A (pt) Solução anti-corrosão
FI970907L (fi) Pyridatsinokinoliiniyhdisteitä
DK0623580T3 (da) 2-Keto-3-methyl-4-hydroxy-valerianesyre
FI943499A7 (fi) Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja
NO930760D0 (no) Substituerte fenyleddiksyreamider
FI942976A7 (fi) 5-amino-8-metyyli-7-pyrrolidinyylikinoliini-3-karboksyylihappojohdannaiset
FI954016A7 (fi) Uudet yhdisteet
DK72693D0 (da) Compounds
NO930722D0 (no) Imidazolylsubstituerte fenyleddiksyreamider
KR960700242A (ko) 8-메톡시퀴놀론카르복실산 유도체(8-methoxyquinolonecarboxylic acid derivative)
FI945092L (fi) Epoksimeripihkahappojohdannaiset
NO961783D0 (no) 5-arylisoxazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
FI932953A7 (fi) Imidazolylsubstituerade fenylpropion- och -kanelsyraderivat
FI933512A7 (fi) 2-substituerade kinolinylmetoxifenylaettiksyraderivat
FI941064A7 (fi) Asyylioksiheksaanihappojohdannaiset
FI933300L (fi) Foerfarande foer rengoering av klorvaetesyra i gasform
FI940040L (fi) Nonatetraeenihappojohdannainen
FI922125L (fi) Mikrobidogiskt foerfarande foer framstaellning av 5-hydroxipyrazinkarboxylsyra